Enerzair Breezhaler (indacaterol/glycopyrronium/mometasone furoate)

pCPA File Number: 21337
Negotiation Status:
Active Negotiation
Indication(s):
Asthma
Sponsor/Manufacturer:
Novartis Pharma Canada Inc.
CADTH Project Number:
SR0645-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable